India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US’ National Institute of Health has said. The NIH said results of two studies of blood serum from people who
Bharat Biotech hereby communicates the following message regarding pricing of COVAXIN® for Central Government, State Governments, and Private Hospitals, we believe it is pertinent to place facts on record for the Media and the public at large, so that they can understand and appreciate our
The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday. This will be followed by the clinical trial of children in the age-group of 2-6
